DVAX

NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Dollar change -0.08
Percentage change -0.73	%

Peers: JNJ PFE MRNA GILD BNTX AZN REGN NVAX VIR VXRT

| Held by: IJR VTI IWM VXF XBI SPSM IWO IBB VTWO IJS

Scroll to Statements

Index	RUT	P/E	61.93	EPS (ttm)	0.17	Insider Own	4.66%	Shs Outstand	125.45M	Perf Week	4.95%
Market Cap	1.32B	Forward P/E	18.90	EPS next Y	0.57	Insider Trans	-0.99%	Shs Float	116.71M	Perf Month	-20.32%
Income	27.31M	PEG	1.14	EPS next Q	0.03	Inst Own	103.30%	Short Float	15.31%	Perf Quarter	-15.07%
Sales	277.25M	P/S	4.78	EPS this Y	72.18%	Inst Trans	-4.47%	Short Ratio	7.19	Perf Half Y	-1.55%
Book/sh	4.76	P/B	2.27	EPS next Y	66.24%	ROA	2.75%	Short Interest	17.86M	Perf Year	-7.99%
Cash/sh	5.83	P/C	1.86	EPS next 5Y	54.24%	ROE	4.48%	52W Range	9.74 - 14.63	Perf YTD	-15.27%
Dividend Est.	-	P/FCF	22.02	EPS past 5Y	-	ROI	3.22%	52W High	-26.04%	Beta	1.28
Dividend TTM	-	Quick Ratio	9.91	Sales past 5Y	177.58%	Gross Margin	82.17%	52W Low	11.09%	ATR (14)	0.49
Dividend Ex-Date	-	Current Ratio	10.80	EPS Y/Y TTM	510.39%	Oper. Margin	-0.75%	RSI (14)	34.11	Volatility	3.99% 4.58%
Employees	405	Debt/Eq	0.43	Sales Y/Y TTM	19.36%	Profit Margin	9.85%	Recom	1.80	Target Price	24.75
Option/Short	Yes / Yes	LT Debt/Eq	0.42	EPS Q/Q	2781.25%	Payout	0.00%	Rel Volume	0.61	Prev Close	10.90
Sales Surprise	-0.92%	EPS Surprise	19.62%	Sales Q/Q	29.56%	Earnings	May 06 AMC	Avg Volume	2.49M	Price	10.82
SMA20	-7.39%	SMA50	-15.88%	SMA200	-10.35%	Trades		Volume	1,508,173	Change	-0.73%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-11-25	Downgrade	Goldman	Neutral → Sell	$15 → $12
Feb-01-24	Initiated	Goldman	Neutral	$20
Sep-27-22	Initiated	JMP Securities	Mkt Outperform	$22
Jan-06-22	Resumed	Goldman	Buy	$38
Aug-06-21	Initiated	Goldman	Buy	$19
Aug-07-20	Reiterated	H.C. Wainwright	Buy	$14 → $12
Aug-03-20	Reiterated	H.C. Wainwright	Buy	$12 → $14
Jun-15-20	Initiated	Evercore ISI	Outperform	$14
Oct-18-19	Initiated	H.C. Wainwright	Buy	$13
Jul-11-19	Upgrade	Cantor Fitzgerald	Neutral → Overweight	$20
Feb-27-19	Reiterated	Cantor Fitzgerald	Overweight	$32 → $28
May-10-18	Upgrade	JP Morgan	Neutral → Overweight
Mar-08-18	Reiterated	Cantor Fitzgerald	Overweight	$25 → $27
Feb-14-18	Downgrade	JP Morgan	Overweight → Neutral
Sep-25-17	Reiterated	RBC Capital Mkts	Outperform	$26 → $28
Sep-15-17	Initiated	Cantor Fitzgerald	Overweight	$24
Jul-31-17	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$7 → $26
Jul-31-17	Upgrade	JP Morgan	Neutral → Overweight
May-09-17	Reiterated	RBC Capital Mkts	Sector Perform	$6 → $7
Apr-28-16	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$48 → $17

Show Previous Ratings

Apr-22-25 04:00PM	Dynavax to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025 (PR Newswire)
Apr-21-25 04:05PM	Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders (Business Wire)
Apr-17-25 09:17AM	GSK's Pentavalent Meningococcal Jab Recommended for Use by ACIP (Zacks)
07:15AM	Dynavax Files Definitive Proxy Statement and Sends Letter to Stockholders (PR Newswire)
Apr-16-25 09:48AM	MURA Soars as it Explores Strategic Options Post Cancer Study Failures (Zacks) -6.66%
08:52AM	Loading…
08:52AM	DTIL Gets FDA's Fast Track Tag for Hepatitis B Gene Therapy, Stock Up (Zacks)
08:00AM	Deep Track Capital Comments on Dynavax Technologies Rejection of Most Recent Settlement Offer (Business Wire)
Apr-15-25 10:20AM	Buy The Dips, Sell The Rips (Seeking Alpha)
Apr-11-25 11:57AM	KROS Initiates Exploring Strategic Alternatives, Stock Gains 18.5% (Zacks)
Apr-10-25 10:53AM	PHIO Stock Soars as Safety Panel Clears Skin Cancer Drug for Next Dose (Zacks) -8.81%
09:58AM	ANIX Gets New Patent for Breast Cancer Vaccine Technology, Stock Up (Zacks)
Apr-09-25 12:57PM	3 Biotech Stocks Holding Their Own (Seeking Alpha)
10:01AM	RXRX Doses First Patient in Early-Stage B-Cell Lymphomas Study (Zacks)
Apr-08-25 12:18PM	AtriCure Drops 25%: Bargain Or Caution Sign? (Seeking Alpha) -5.92%
11:29AM	PCRX Stock Soars on Exparel Patent Settlement With Generic Players (Zacks)
11:21AM	Loading…
11:21AM	RYTM Stock Rises 17% on Meeting Goals in Hypothalamic Obesity Study (Zacks)
Apr-07-25 10:53AM	AZN Gets EU Nod for Expanded Use of Two Separate Cancer Drugs (Zacks)
Apr-04-25 01:45PM	Bayer's Vividion Initiates Dosing in Early-Stage Cancer Study (Zacks)
01:10PM	AMGN's Uplizna Gets FDA Nod for 2nd Rare Autoimmune Disease Indication (Zacks)
09:37AM	PCRX Doses First Patient in Phase II PCRX-201 Gene Therapy Study (Zacks)
Apr-03-25 05:40PM	Dynavax Files Preliminary Proxy Statement (PR Newswire)
11:27AM	SNY's Rilzabrutinib Gets FDA's Orphan Drug Tag for Two Rare Diseases (Zacks)
09:32AM	DNLI Begins Rolling BLA Submission for Hunter Syndrome Drug, Stock Up (Zacks)
Apr-02-25 11:29AM	AXSM Stock Down on Top-Line Data From Depression Study on Solriamfetol (Zacks)
Apr-01-25 10:55AM	VRTX Provides Mixed Updates for Type 1 Diabetes Pipeline Candidates (Zacks)
09:31AM	AstraZeneca's Imfinzi Gets FDA Nod for Bladder Cancer Indication (Zacks)
Mar-31-25 09:57AM	Moderna, biotech stocks slide following resignation of FDA official Peter Marks (Yahoo Finance) -5.19%
Mar-28-25 09:45AM	Kodiak Q4 Loss Narrower Than Expected, Pipeline Development in Focus (Zacks)
09:26AM	BEAM's IND for BEAM-302 in Genetic Disorder Study Gets FDA Clearance (Zacks)
Mar-27-25 12:37PM	Bayer Licenses PRMT5 inhibitor From Suzhou Puhe BioPharma (Zacks)
09:39AM	Loading…
09:39AM	PLRX Stock Plunges 89% in 3 Months: Here's What Investors Should Know (Zacks)
Mar-25-25 12:44PM	Will Alkermes' Proprietary Drugs Aid Growth Amid Stiff Competition? (Zacks)
11:51AM	UBX Stock Down 29% on Mixed Results From Phase II Eye Disease Study (Zacks)
Mar-24-25 02:36PM	EMA Accepts GSK's Filing for Expanded Use of Nucala in COPD (Zacks)
Mar-21-25 12:46PM	Alnylam Gets FDA Nod for Expanded Use of Amvuttra in Cardiomyopathy (Zacks)
12:44PM	OPTN Stock Soars 53% on Inking $330M Deal to be Acquired by Paratek (Zacks)
12:39PM	Pacira Surges 66.8% in Six Months: How Should You Play the Stock? (Zacks)
12:37PM	Mirum's Heavy Dependence on Livmarli for Revenues Remains a Woe (Zacks)
12:17PM	PSTV Stock Surges as FDA Accepts Proprietary Name for Lead Drug (Zacks)
09:26AM	ESPR to Study Bempedoic Acid in Pediatric Familial Hypercholesterolemia (Zacks)
Mar-20-25 12:23PM	Puma Biotechnology Stock Rises 35% in 6 Months: Here's Why (Zacks)
10:44AM	Why Dynavax Technologies (DVAX) Stock Might be a Great Pick (Zacks)
10:19AM	IMVT Unlikely to Pursue Batoclimab for MG & CIDP Despite Success (Zacks)
09:34AM	Novartis Reports Updated Positive Data From Phase III SMA Program (Zacks)
Mar-19-25 10:59AM	JNJ's Nipocalimab Gets FDA's Fast Track Tag for Sjogren's Disease (Zacks)
Mar-12-25 09:55AM	Wall Street Analysts See an 83.1% Upside in Dynavax Technologies (DVAX): Can the Stock Really Move This High? (Zacks)
Mar-10-25 08:00AM	Deep Track Capital Sends Letter to Dynavax Technologies Board of Directors (Business Wire)
Mar-06-25 06:00AM	Dynavax Announces Convertible Debt Refinancing and Common Stock Share Repurchase (PR Newswire)
Mar-02-25 12:36PM	Is Dynavax Technologies Corporation (DVAX) the Best Small Cap Pharma Stock to Buy Now? (Insider Monkey)
Feb-25-25 04:10PM	Dynavax to Participate in Upcoming Investor Conferences (PR Newswire)
Feb-24-25 09:55AM	Wall Street Analysts Think Dynavax Technologies (DVAX) Could Surge 81.92%: Read This Before Placing a Bet (Zacks)
Feb-21-25 12:59PM	MercadoLibre Stock Hits New High As Company Delivers Profits (Investor's Business Daily)
02:14AM	Dynavax Technologies Corp (DVAX) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com)
Feb-20-25 09:30PM	Dynavax Technologies (DVAX) Q4 2024 Earnings Call Transcript (Motley Fool)
05:10PM	Dynavax Technologies (DVAX) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
04:15PM	Dynavax Technologies: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	Dynavax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Financial Guidance (PR Newswire)
Feb-19-25 04:52PM	Dynavax Responds to Deep Track and Highlights Long-Term Value Creation Strategy (PR Newswire)
09:00AM	Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies Board of Directors at 2025 Annual Meeting (Business Wire)
08:04AM	Investor Deep Track launches proxy fight at Dynavax, nominates 4 directors (Reuters)
Feb-11-25 03:11PM	Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B Uncertainty (Benzinga)
Feb-06-25 05:42PM	Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025 (PR Newswire)
Jan-29-25 09:55AM	Wall Street Analysts Believe Dynavax Technologies (DVAX) Could Rally 93.2%: Here's is How to Trade (Zacks)
Jan-27-25 06:00AM	Dynavax Advances Board Refreshment Program (PR Newswire)
Jan-16-25 12:00PM	Dynavax Technologies (DVAX) Upgraded to Buy: Here's What You Should Know (Zacks)
Jan-14-25 09:29AM	Dynavax Reports Revenue Growth and Defense Contract (TipRanks)
Jan-13-25 09:00AM	Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Highlights (PR Newswire)
Jan-03-25 08:30AM	Implied Volatility Surging for Dynavax Technologies (DVAX) Stock Options (Zacks)
Nov-27-24 09:55AM	Does Dynavax Technologies (DVAX) Have the Potential to Rally 93.52% as Wall Street Analysts Expect? (Zacks)
Nov-26-24 04:05PM	Dynavax to Present at the 7th Annual Evercore HealthCONx Conference (PR Newswire)
Nov-25-24 09:03AM	Do Options Traders Know Something About Dynavax Technologies (DVAX) Stock We Don't? (Zacks)
Nov-19-24 08:50AM	Dynavax Technologies Corporation (DVAX): This Small-Cap Stock Is Ready To Explode (Insider Monkey)
Nov-11-24 12:00PM	Dynavax Technologies (DVAX) Upgraded to Buy: Here's Why (Zacks)
09:55AM	Wall Street Analysts Predict an 88.32% Upside in Dynavax Technologies (DVAX): Here's What You Should Know (Zacks)
08:00AM	Dynavax Announces $100 Million Accelerated Share Repurchase Program (PR Newswire)
Nov-08-24 12:02PM	Dynavax Technologies Corp (DVAX) Q3 2024 Earnings Call Highlights: Record Hep B Sales and ... (GuruFocus.com) +8.24%
Nov-07-24 11:15PM	Dynavax Technologies (DVAX) Q3 2024 Earnings Call Transcript (Motley Fool)
05:25PM	Dynavax Technologies (DVAX) Q3 Earnings Surpass Estimates (Zacks)
04:18PM	Dynavax Technologies: Q3 Earnings Snapshot (Associated Press Finance)
04:02PM	Dynavax Reports Third Quarter 2024 Financial Results and Provides Business Updates (PR Newswire)
04:01PM	Dynavax Announces $200 Million Share Repurchase Program (PR Newswire)
Nov-01-24 06:33PM	Bath & Body Works, Paramount Global, and More Stocks See Action From Activist Investors (Barrons.com)
Oct-29-24 08:30AM	Dynavax Adopts Limited-Duration Stockholder Rights Plan (PR Newswire)
Oct-24-24 09:08PM	Deep Track Capital, LP Reduces Stake in Dynavax Technologies Corp (GuruFocus.com)
04:10PM	Dynavax to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024 (PR Newswire)
Oct-16-24 01:04PM	State Street Corp's Strategic Reduction in Dynavax Technologies Holdings (GuruFocus.com)
Oct-09-24 05:07PM	Dynavax Technologies Corp (DVAX) Q2 2024 Earnings Call Highlights: Record HEPLISAV-B Sales and ... (GuruFocus.com)
Sep-20-24 06:39PM	Lennar, Bitdeer, and More Stocks See Action From Activist Investors (Barrons.com)
Sep-16-24 07:02PM	Deep Track Capital, LP Increases Stake in Dynavax Technologies Corp (GuruFocus.com)
Sep-12-24 01:13AM	Federated Hermes, Inc. Reduces Stake in Dynavax Technologies Corp (GuruFocus.com)
Sep-05-24 08:30AM	Lantheus Appoints Julie Eastland as New Board Member (GlobeNewswire)
Aug-09-24 09:55AM	How Much Upside is Left in Dynavax Technologies (DVAX)? Wall Street Analysts Think 135.98% (Zacks)
Aug-06-24 11:30PM	Dynavax Technologies (DVAX) Q2 2024 Earnings Call Transcript (Motley Fool) +6.97%
07:10PM	Dynavax Technologies (DVAX) Tops Q2 Earnings Estimates (Zacks)
06:11PM	Dynavax Technologies: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	Dynavax Reports Second Quarter 2024 Financial Results and Provides Business Updates (PR Newswire)
Jul-23-24 04:00PM	Dynavax to Report Second Quarter 2024 Financial Results and Host Conference Call on August 6, 2024 (PR Newswire)
Jun-28-24 04:32AM	Dynavax doses first subject in Phase I/II shingles vaccine trial (Clinical Trials Arena)
Jun-27-24 04:09PM	Dynavax Initiates Phase 1/2 Study of Novel Shingles Vaccine Program (PR Newswire)
May-28-24 04:18PM	Dynavax to Present at Upcoming Investor Conferences (PR Newswire)

Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the provision of discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Novack David F	President & COO	Mar 24 '25	Option Exercise	6.80	10,000	68,050	18,078	Mar 26 05:04 PM
Novack David F	President & COO	Mar 24 '25	Sale	14.00	10,000	140,000	8,078	Mar 26 05:04 PM
DAVID NOVACK	Officer	Mar 24 '25	Proposed Sale	14.00	10,000	140,000		Mar 24 04:23 PM
Novack David F	President & COO	Mar 18 '25	Sale	13.58	14,020	190,392	8,078	Mar 20 06:15 PM
DAVID NOVACK	Officer	Mar 18 '25	Proposed Sale	13.58	14,020	190,386		Mar 18 04:17 PM
Novack David F	President & COO	Mar 07 '25	Sale	14.39	32,764	471,474	22,098	Mar 10 09:44 PM
DAVID NOVACK	Officer	Mar 07 '25	Proposed Sale	14.39	32,764	471,376		Mar 07 05:16 PM
CANO FRANCIS	Director	May 31 '24	Sale	11.93	3,615	43,127	36,905	Jun 03 05:37 PM
CANO FRANCIS	Director	May 24 '24	Option Exercise	5.90	7,500	44,250	44,405	May 28 08:18 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Dynavax Technologies Corp

Upgrade your FINVIZ experience